Categories: Business News

Corona Remedies IPO: Shares Shine On NSE & BSE With 38% Listing Premium, Signaling Strong Investor Confidence On Dalal Street

Corona Remedies debuted strongly on Dalal Street, listing at hefty premiums on NSE and BSE after massive IPO demand, signaling investor confidence, fundamentals, and a promising start in public markets.

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by Aishwarya Samant
Published: December 15, 2025 12:34:16 IST

Corona Remedies share price: The opening of the Corona Remedies share price was head-turning at Dalal Street, and understandably so. A bold venture into the secondary market was evident in the fact that the stock made a healthy entry, with no interest turning away as soon as the IPO window was shut.

When you are looking at the share price of Corona Remedies today, the opening contrasted this positive result, and the company has listed at a steep price above its IPO price and immediately captured market interest.

So a question and curiosity raises, what drove this buzz? The solution is the strong demand that the company had received during the public issue process, which flowed well into listing day. Add to that a conducive wider market atmosphere, and you have the ideal ingredients for a good debut. For sideliners, this was no ordinary listing, as it served as a reminder that when fundamentals combine with timing, markets are likely to reward confidence. Whether it is too late to invest or just read between the lines, the opening of Corona Remedies definitely got Dalal Street on alert.

Market Performance: Corona Remedies Share Price Today On NSE and BSE

  • Strong NSE debut: Corona Remedies shares opened firmly on the NSE, delivering a solid premium at the opening bell.
  • NSE listing price: ₹1,470 per share
  • Premium over IPO price (NSE): 38.42%
  • BSE listing price: ₹1,452 per share
  • Premium over IPO price (BSE): 36.72%
  • Post-listing market capitalisation: ₹8,880.44 crore, signaling a confident and well-received entry into the public markets.

Corona Remedies On BSE

  • The Corona Remedies share price on the BSE reflected strong investor enthusiasm.
  • The stock listed at ₹1,452 per share, delivering a solid premium over its IPO price.
  • Pricing on the BSE closely matched the NSE listing, showing consistency across exchanges.
  • This parallel performance suggests broad-based investor interest, not exchange-specific trading.

Corona Remedies IPO Snapshot: Key Numbers and Listing Highlights

Category Details
Issue Size ₹655.37 crore
Price Band ₹1,008 – ₹1,062 per share
Anchor Investment Raised ₹195 crore
Subscription Response 137.04x overall subscription
NSE Listing Premium Nearly 38% over IPO price
BSE Listing Performance Similar strong premium
Market Debut Outlook Strong listing sets a positive tone
Overall Assessment Firm entry into public markets; one of the session’s notable listings
Corona Remedies is a drug formulations company based in Ahmedabad which is engaged in developing, producing, and selling of medicines in major therapeutic areas. Its portfolio consists of women’s health care, cardio-diabeto, pain management, urology, and other chronic therapies with 67 well-known brands established by December 2024.
(With Inputs)

Recent Posts

Marco Rubio Goes Viral For ‘Maduro Nike Tech’ Look En Route To Beijing, Social Media Reacts

US Secretary of State Marco Rubio went viral after wearing a grey Nike Tech tracksuit…

May 13, 2026

Spotify Outage: What We Know About The Music App Being Down Before Service Was Restored

Spotify Outage: Spotify faced a major global outage that left thousands of users unable to…

May 13, 2026

Assam Emerging As Major Contributor To Stronger India-US Ties: Himanta Sarma

Himanta Biswa Sarma met US Ambassador to India Sergio Gor and said Assam can play…

May 13, 2026